Although significant differences in IL-17F-modulated signaling between CLL and healthy B cells were identified, analysis of receptor expression levels in a subset of donors suggested that IL-17RA and IL-17RC receptor expressions were comparable between CLL and healthy B cells (data not shown). This evidence concerns the gene IL17RA and B-cell chronic lymphocytic leukemia.